Table 2.
Medical and admission characteristics of 37 881 eligible recipients of total hip arthroplasty before surgery and subsequent complications
| Data | |
|---|---|
| Medical characteristics | |
| No (%) by comorbidities: | |
| Frail | 1953 (5.2) |
| Congestive heart failure | 1933 (5.1) |
| Chronic kidney disease | 912 (2.4) |
| Chronic obstructive pulmonary disease | 6117 (16.1) |
| Diabetes | 5668 (15.0) |
| Hypertension | 22 865 (60.4) |
| No (%) by Charlson score: | |
| 0 | 34 500 (91.1) |
| 1 | 1700 (4.5) |
| ≥2 | 1681 (4.4) |
| Median (IQR) Charlson score | 0 (0-0) |
| Admission characteristics | |
| No (%) of teaching hospitals | 12 978 (34.3) |
| Median (IQR) hospital volume* | 211 (150-341) |
| Median (IQR) surgeon experience (years) | 19 (11-27) |
| No (%) by medical school of surgeon: | |
| Canadian | 29 359 (77.5) |
| International | 6331 (16.7) |
| Unknown | 2191 (5.9) |
| Complications | |
| No (%) by complication within 2 years: | |
| Infection | 407 (1.1) |
| Dislocation | 458 (1.2) |
| Periprosthetic fracture | 138 (0.4) |
| Revision | 429 (1.1) |
| No (%) by complications within 90 days: | |
| Venous thromboembolism | 533 (1.4) |
| Death | 178 (0.5) |
IQR=interquartile range.
*No of total hip arthroplasties in 365 days before surgery.